News

PBMs have launched clinical programs pairing GLP-1 prescriptions with pharmacist coaching, nutrition support, behavioral health partnerships, and digital tools to improve adherence and outcomes.

CMS boosts Medicare Advantage 2027 rates by 2.48%; Michael Lutz and Ceci Connolly warn MA plans still face inflation and risk-adjustment inequities.

The investigators applied a multinomial statistical model to evaluate associations between individual CT features and final radiologic diagnoses.

A review of clinical trials and genetic, immune, and environmental factors revealed that Asian patients with advanced HER2-negative gastric cancer generally experience higher response rates and longer survival with immunotherapy than non-Asian patients.

A March 2026 study found that U.S. cancer patients with hypertension, hyperlipidemia or diabetes face consistently higher healthcare costs, which increased steadily from 2012 to 2018, dropped during the COVID-19 pandemic and remain elevated compared with patients without these conditions.

New research suggests that when adolescents sleep, not just how long, may play a significant role in shaping their eating habits and activity levels, particularly during the school year.

A new meta-analysis of prospective studies finds artificial intelligence performs similarly to dermatologists in melanoma detection, although more rigorous research is needed before it can be considered as a reliable decision-support tool in routine care.

The California insurer is continuing the program, called Virtual Blue, but also looking to add more virtual care into its standard offerings.

Yuvezzi treats presbyopia, or blurry vision due to aging, and is available at retail pharmacies or PHIL, an ePharmacy platform.

Lenox Hill Hospital’s controversial $2 billion redevelopment includes a new mental health clinic, a shorter tower, and expanded emergency, surgical, and maternity facilities.

Dermatology performance measures need to be streamlined and redesigned to better capture meaningful patient outcomes while reducing administrative burden and aligning with value-based care.

The two oral GLP-1s will battle for market share. Foundayo is a small-molecule drug that can be taken with food. Some data suggest that oral Wegovy is slightly better at producing weight loss.

Women who experience menopause before age 40 face a significantly higher risk of coronary heart disease, according to new research by researchers at Northwestern Medicine.

USF Health researchers have discovered how opioid receptors work in reverse, which could allow for medications to boost pain relief without causing dangerous side effects.

The Phoenix-based nonprofit health system had $16 billion in revenues in 2025 and reported $1.1 billion in community benefits in its 2025 annual report.

Doctors Without Borders has accused Gilead of restricting access to its HIV prevention drug lenacapavir by refusing humanitarian sales and limiting supply, arguing this is hindering global efforts to expand HIV prevention in high-need regions.

A new report found that despite widespread AI adoption in U.S. health systems, many patients still struggle to access care due to gaps in communication, trust and care navigation.

Alkermes has initiated a phase 3 clinical program evaluating alixorexton for narcolepsy type 1 and type 2, with additional development underway for idiopathic hypersomnia.

A long-term extension trial of 389 patients found Attruby significantly cut death risk in transthyretin amyloid cardiomyopathy, with no new safety concerns identified.

Eli Lilly announced this morning that the FDA has approved its oral GLP-1, orforglipron, which the company is marketing under the brand name Foundayo. The competition between Foundayo and oral Wegovy is expected to be fierce.

A new preclinical study found that inhibiting the enzyme LSD1 can activate the skin’s immune system and suppress tumor growth, pointing to a potential new topical treatment for skin cancer.

A study published March 20 in Nature found that a mechanosensitive piezo1–IL-33 signaling pathway in vascular endothelial cells is associated with pulmonary fibrosis and may represent a potential therapeutic target.

Researchers found that lung function showed only a weak relationship with quality-of-life outcomes, highlighting perhaps the value of broader patient-reported or caregiver-reported outcomes in clinical care and research.

Van Beek, a clinical

Novo Nordisk is offering the subscriptions through telehealth providers Ro, WeightWatchers and LifeMD. Others are expected to follow.

Get clear, expert-backed answers to the biggest questions surrounding the Great Healthcare Plan, with insights from Emma Wager of KFF and industry experts including Jeffrey Casberg, Lindsay Bealor Greenleaf and Luke Greenwalt. This FAQ breaks down what proposed changes to drug pricing, PBMs, subsidies and insurance coverage could mean for your organization — and what to watch as policies take shape.

Preliminary data from a preclinical study show that vialinin-A, a compound isolated from Chinese mushrooms, is an antioxidant that has an anti-inflammatory effect.

Incyte’s phase 3 STOP-HS data show that povorcitinib improved symptoms of moderate to severe hidradenitis suppurativa in most patients over 54 weeks with a generally well-tolerated safety profile.